𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast

✍ Scribed by Stavroula Droufakou; Vinay Deshmane; Rebecca Roylance; Andrew Hanby; Ian Tomlinson; Ian R. Hart


Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
163 KB
Volume
92
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


The cell-cell adhesion receptor gene E-cadherin (CDH1) is expressed by epithelial cells, in which it mediates adhesion and morphogenesis. Invasive lobular carcinoma (ILC) characteristically infiltrates diffusely as single cells; by immunohistochemistry, many of these tumours lack E-cadherin expression. In the present study we investigated various ways in which loss of function of the E-cadherin gene could occur in ILCs, namely, promoter methylation, mutation and allelic loss. We analysed 22 ILCs and found 12 (55%) E-cadherin-negative samples by immunohistochemical analysis. Methylation-specific polymerase chain reaction (PCR) showed that 17/22 (77%) of these tumours had methylation of the CDH1 promoter, including 11/12 (91%) of the E-cadherin-negative tumours. All 16 exons of E-cadherin (including intron-exon boundaries) were amplified from chromosomal DNA and screened for mutations by conformation-sensitive gel electrophoresis (CSGE). Bands with altered mobility were analysed by direct sequencing. We identified five frameshift mutations, which resulted in downstream stop codons and one splice site mutation in six different tumours (29%). Loss of heterozygosity (LOH) was assessed using microsatellite markers, and 9/18 (50%) informative tumours showed LOH. We conclude that most ILCs show genetic or epigenetic changes affecting the E-cadherin gene and that many of these tumours lack E-cadherin expression. In all cases in which there was loss of expression, this was consistent with biallelic inactivation of CDH1 by promoter methylation, mutation or allelic loss in any combination.


πŸ“œ SIMILAR VOLUMES


Epigenetic silencing of maspin gene expr
✍ Frederick E. Domann; Judd C. Rice; Mary J.C. Hendrix; Bernard W. Futscher πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 135 KB πŸ‘ 2 views

Maspin is a tumor suppressor whose expression is lost in many advanced breast cancers. Maspin has been shown to inhibit cell motility, invasion and metastasis; however, its precise role in normal mammary epithelium remains to be elucidated. Although expression of maspin mRNA is low or absent in most

Lobular carcinoma in situ of the breast(
✍ James E. Wheeler; H. T. Enterline; James M. Roseman; Joseph P. Tomasulo; Cheryl πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 924 KB

Ninety-eight women with lobular carcinoma in situ (LICS) of the breast were identified over a 16-year period. Consecutive slide review of all breast material over a 12-year period identified 25 women with LCIS o n biopsy who.did not undergo mastectomy. Only 1 woman (4%) in a complete followup averag